kemiasthanCD20throughthemulti—parameterflow— cytometryanalysisofleukemiacells.tIlesamplesfrom321patients withacuteleukemia(AL,wereimmunophenotypedbymulti— colorflowcytometryandCD45/SSCgatingstrategyfol— lowedbytheanalysisofCD19andCD20expression.Theresultsshowedthatthepositiverateo fCD19(115/116.99. 1%)inll6...
Ginaldi L, De Martinis M, Matutes E, Farahat N, Morilla R, Catovsky D. Levels of expression of CD19 and CD20 in chronic B cell leukaemias. J Clin Pathol. 1998; 51 (5):364–369. doi: 10.1136/jcp.51.5.364. [ Cross Ref ]
10 patients had positive expression of both CD19 and CD20 as confirmed by immunohistochemistry. Safety and adverse events Eleven patients received CD19/20 CAR-T cell products. Five patients (45%) developed CRS with a median onset of 4 days after infusion (range 1–16) and a median duration...
Possible role of CD22, CD79b and CD20 expression in distinguishing small lymphocytic lymphoma from chronic lymphocytic leukemia Flow cytometry has an important role in diagnosis and classification of B-cell lymphoproliferative disorders (BCLPDs). However, in distinguishing chronic l... D Jovanovic,P ...
Specifically, CD20 expression at diagnosis predicts relapse in adult patients, such that CD20-directed antibody therapy is now being incorporated into front-line therapy for adult BL-ALL [25, 26]. Based on these observations, we hypothesized that simultaneous targeting of CD20 and CD22 could ...
不同治疗方案对原发免疫性血小板减少症患者外周血B细胞抗原CD19、CD20、CD80、CD86表达的影响
MS4A1CD20 protein, recombinant IL1R1IL1R1 protein, recombinant LEPRLeptin Receptor protein, recombinant CD1BCD1B protein, recombinant CLEC7ADectin-1/CLEC7A protein, recombinant CDH5VE-Cadherin protein, recombinant IL10RAIL-10RA/IL-10R alpha protein, recombinant ...
A case of lymphoma of T-cell derivation with aberrant expression of three B-cell lineage markers (CD19, CD20, and CD79a), which was diagnosed on a left axillary excision, is described. Immunohistochemical studies and flow cytometry analysis demonstrated neoplastic cells expressing CD3, CD19, CD20...
26.根据权利要求7、12、16或17所述的双特异性抗体或抗原结合片段,其中所述双特异 性抗体或抗原结合片段与CD3、CD4、CD8、CD20、CD19、CD21、CD23、CD46、CD80、HLA‑DR、CD74、 CD19、CD14、CD15、CD16、CD123、TCRγ/δ、NKp46、KIR或小分子DOTA半抗原结合。 27.一种用于治疗有需要的受试者的CD19...
(1:20 diluted). For flow cytometric analysis of CD19/CD20 expression, untouched primary myeloma cells were washed and stained with anti-CD38-AF488, anti-CD138-PE, and anti-CD19-AF647, anti-CD20-AF647, or AF647 isotype control (all 1:20 diluted). according to the manufacturer’s ...